erythromycin has been researched along with dicumarol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Anderson, EE; Banerjee, T; Bork, P; Cacace, E; Eberl, C; Forslund, SK; Garcia-Santamarina, S; Gekeler, C; Goemans, CV; Kuhn, M; Löber, U; Maier, L; Milanese, A; Müller, P; Patil, KR; Pruteanu, M; Stecher, B; Typas, A; Wirbel, J; Zeller, G; Zhang, B; Zimmermann, M | 1 |
2 other study(ies) available for erythromycin and dicumarol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Unravelling the collateral damage of antibiotics on gut bacteria.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Bacteroides; Clostridioides difficile; Dicumarol; Erythromycin; Feces; Female; Gastrointestinal Microbiome; Germ-Free Life; Humans; Macrolides; Male; Mice; Microbiota; Symbiosis; Tetracyclines | 2021 |